• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姑息性放射治疗对晚期胃癌患者的影响:一项回顾性队列研究的结果

The Impact of Palliative Radiation Therapy on Patients With Advanced Gastric Cancer: Results of a Retrospective Cohort Study.

作者信息

Katano Atsuto, Yamashita Hideomi

机构信息

Radiology, The University of Tokyo Hospital, Tokyo, JPN.

出版信息

Cureus. 2022 Dec 26;14(12):e32971. doi: 10.7759/cureus.32971. eCollection 2022 Dec.

DOI:10.7759/cureus.32971
PMID:36712736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9876699/
Abstract

Aim In advanced gastric cancer, symptoms such as loss of appetite, stomach tightness, occasional pain, vomiting blood, and melena may occur. Palliative radiation therapy may be indicated in such cases. This study aimed to investigate the clinical outcomes of palliative radiotherapy in patients with advanced-stage gastric carcinoma. Methods From April 2018 to October 2022, consecutive patients with non-resected advanced gastric cancer who received radiation therapy for palliation of symptoms were included. Results A total of 23 patients with advanced-stage gastric carcinoma were analyzed in this study. Twelve male and 11 female patients were included. The median overall survival period was 3.9 months (95% confidence interval: 1.0-8.7 months). Sixteen patients required erythrocyte transfusion before radiotherapy; for 13 patients (83%), the required units of erythrocyte transfusion decreased after palliative radiotherapy. The mean erythrocyte transfusion units significantly decreased from 4.2 (standard deviation [SD]: 4.3) to 1.7 (SD: 3.6) (p = 0.02). No adverse events of grade ≥3 were observed in this study population. Conclusion Palliative radiation therapy for advanced gastric cancer yielded a good response rate and can be a useful treatment option.

摘要

目的 在晚期胃癌中,可能会出现食欲不振、胃部紧绷、偶尔疼痛、吐血和黑便等症状。在此类情况下,可能需要进行姑息性放射治疗。本研究旨在调查晚期胃癌患者姑息性放疗的临床疗效。方法 纳入2018年4月至2022年10月期间连续接受放疗以缓解症状的未切除晚期胃癌患者。结果 本研究共分析了23例晚期胃癌患者。其中男性12例,女性11例。中位总生存期为3.9个月(95%置信区间:1.0 - 8.7个月)。16例患者在放疗前需要输血;13例患者(83%)在姑息性放疗后所需输血量减少。平均输血量从4.2(标准差[SD]:4.3)显著降至1.7(SD:3.6)(p = 0.02)。本研究人群未观察到≥3级不良事件。结论 晚期胃癌的姑息性放射治疗有效率良好,可作为一种有用的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b87/9876699/c10a62769b55/cureus-0014-00000032971-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b87/9876699/ab2bd91dd345/cureus-0014-00000032971-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b87/9876699/c10a62769b55/cureus-0014-00000032971-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b87/9876699/ab2bd91dd345/cureus-0014-00000032971-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b87/9876699/c10a62769b55/cureus-0014-00000032971-i02.jpg

相似文献

1
The Impact of Palliative Radiation Therapy on Patients With Advanced Gastric Cancer: Results of a Retrospective Cohort Study.姑息性放射治疗对晚期胃癌患者的影响:一项回顾性队列研究的结果
Cureus. 2022 Dec 26;14(12):e32971. doi: 10.7759/cureus.32971. eCollection 2022 Dec.
2
Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort study.姑息性放疗对不可切除的晚期胃癌患者胃出血的疗效:一项回顾性队列研究。
BMC Palliat Care. 2015 Aug 4;14:37. doi: 10.1186/s12904-015-0034-y.
3
The role of palliative radiation therapy in symptomatic locally advanced gastric cancer.姑息性放射治疗在有症状的局部晚期胃癌中的作用。
Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):385-8. doi: 10.1016/j.ijrobp.2006.08.070. Epub 2006 Nov 21.
4
Outcomes After Surgical Palliation of Patients With Gastric Cancer.胃癌患者手术姑息治疗后的结局
J Surg Res. 2022 Nov;279:304-311. doi: 10.1016/j.jss.2022.06.018. Epub 2022 Jul 6.
5
Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma.晚期和复发性卵巢癌的有效姑息性放射治疗
Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1256-63. doi: 10.1016/s0360-3016(01)01733-3.
6
Clinical outcome of palliative radiotherapy for locally advanced symptomatic gastric cancer in the modern era.现代姑息性放疗用于局部晚期有症状胃癌的临床疗效
Medicine (Baltimore). 2014 Nov;93(22):e118. doi: 10.1097/MD.0000000000000118.
7
Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer.姑息性外照射放疗治疗不可切除的晚期胃癌肿瘤出血。
BMC Cancer. 2017 Aug 12;17(1):541. doi: 10.1186/s12885-017-3508-x.
8
Palliative radiotherapy in symptomatic locally advanced gastric cancer: A phase II trial.姑息性放疗治疗有症状局部晚期胃癌的Ⅱ期临床试验。
Cancer Med. 2019 Apr;8(4):1447-1458. doi: 10.1002/cam4.2021. Epub 2019 Feb 20.
9
Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer.姑息性放疗在控制不可切除的晚期胃癌患者出血中的作用。
BMC Cancer. 2021 Apr 15;21(1):413. doi: 10.1186/s12885-021-08145-4.
10
Palliative radiotherapy for gastric cancer bleeding: a multi-institutional retrospective study.胃癌出血的姑息性放疗:多机构回顾性研究。
BMC Palliat Care. 2022 Apr 12;21(1):52. doi: 10.1186/s12904-022-00943-2.

本文引用的文献

1
Efficacy of local hemostatic agents after endoscopic submucosal dissection: a meta-analysis.内镜黏膜下剥离术后局部止血剂疗效的 Meta 分析。
Minim Invasive Ther Allied Technol. 2022 Oct;31(7):1017-1025. doi: 10.1080/13645706.2022.2111217. Epub 2022 Aug 24.
2
Gastric cancer and genomics: review of literature.胃癌与基因组学:文献综述。
J Gastroenterol. 2022 Aug;57(8):505-516. doi: 10.1007/s00535-022-01879-3. Epub 2022 Jun 25.
3
Palliative Radiotherapy for Bleeding from Unresectable Gastric Cancer Using Three-Dimensional Conformal Technique.
使用三维适形技术对不可切除胃癌出血进行姑息性放疗
Biomedicines. 2022 Jun 13;10(6):1394. doi: 10.3390/biomedicines10061394.
4
Palliative radiotherapy for gastric cancer bleeding: a multi-institutional retrospective study.胃癌出血的姑息性放疗:多机构回顾性研究。
BMC Palliat Care. 2022 Apr 12;21(1):52. doi: 10.1186/s12904-022-00943-2.
5
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.纳武利尤单抗联合化疗对比安慰剂联合化疗用于治疗人表皮生长因子受体 2(HER2)阴性、未经治疗、不可切除的晚期或复发性胃或胃食管结合部腺癌患者(ATTRACTION-4):一项随机、多中心、双盲、安慰剂对照、3 期临床试验。
Lancet Oncol. 2022 Feb;23(2):234-247. doi: 10.1016/S1470-2045(21)00692-6. Epub 2022 Jan 11.
6
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
7
History and emerging trends in chemotherapy for gastric cancer.胃癌化疗的历史与新趋势
Ann Gastroenterol Surg. 2021 Feb 1;5(4):446-456. doi: 10.1002/ags3.12439. eCollection 2021 Jul.
8
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.一线纳武利尤单抗联合化疗与单纯化疗治疗晚期胃癌、胃食管交界癌和食管腺癌(CheckMate 649):一项随机、开放标签的3期试验。
Lancet. 2021 Jul 3;398(10294):27-40. doi: 10.1016/S0140-6736(21)00797-2. Epub 2021 Jun 5.
9
Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer.姑息性放疗在控制不可切除的晚期胃癌患者出血中的作用。
BMC Cancer. 2021 Apr 15;21(1):413. doi: 10.1186/s12885-021-08145-4.
10
Peri-operative Outcomes and Survival Following Palliative Gastrectomy for Gastric Cancer: a Systematic Review and Meta-analysis.胃癌姑息性胃切除术后的围手术期结局与生存:一项系统评价和荟萃分析
J Gastrointest Cancer. 2021 Mar;52(1):41-56. doi: 10.1007/s12029-020-00519-4. Epub 2020 Sep 22.